Serum magnesium as a biochemical and pharmacological risk marker for arrhythmias in chronic cardiovascular disease
Tropical Journal of Pharmaceutical Research · 2026 · 25 (10) · 1365-1371
DOI: 10.4314/tjpr.v25i10.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Journal of Pharmaceutical Research, 2026. Verfasst von Omer Al-Doori und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To estimate the point prevalence of hypomagnesemia among adults with chronic cardiovascular disease (CVD) and its association with arrhythmias, left ventricular ejection fraction (LVEF), and exposure to commonly prescribed cardiovascular medications.
Methods
This cross-sectional study was conducted at Al-Kindy Teaching Hospital, Baghdad, Iraq, from March 2023 to August 2024. The study included 200 adults with established CVD and 100 healthy controls. Serum magnesium was measured using a standardized colorimetric assay, with hypomagnesemia defined as < 1.8 mg/dL. Arrhythmias were assessed by 12-lead electrocardiography and LVEF by transthoracic echocardiography. Medication exposure was obtained from medical records and patient interviews.
Results
Hypomagnesemia was significantly more prevalent among patients with CVD compared with controls (p < 0.001) and independently associated with arrhythmias (odds ratio [OR] = 2.3; 95 % confidence interval [CI]: 1.4 – 3.8; p = 0.001). Each 0.1 mg/dL decrease in serum magnesium was associated with a 0.15 % reduction in LVEF (β = −0.15; 95 % CI: −0.25 to −0.05; p = 0.002). Furthermore, hypomagnesemia was more frequent among users of diuretics, proton pump inhibitors, angiotensin-converting enzyme inhibitors, and digoxin.
Conclusion
Hypomagnesemia was common among patients with CVD, and independently associated with arrhythmias.
Zitieren
APA
Al-Doori, O., Al-Hassani, Z., Ali, S. A., Jalil, H., Abbood, M., & Hasan, A. (2026). Serum magnesium as a biochemical and pharmacological risk marker for arrhythmias in chronic cardiovascular disease. Tropical Journal of Pharmaceutical Research, 25(10), 1365-1371. https://doi.org/10.4314/tjpr.v25i10.4
Vancouver
Al-Doori O, Al-Hassani Z, Ali SA, Jalil H, Abbood M, Hasan A. Serum magnesium as a biochemical and pharmacological risk marker for arrhythmias in chronic cardiovascular disease. Tropical Journal of Pharmaceutical Research. 2026;25(10):1365-1371. doi:10.4314/tjpr.v25i10.4
BibTeX
@article{AlDoori2026,
author = {Al-Doori, Omer and Al-Hassani, Zahraa and Ali, Sura Abid and Jalil, Hayder and Abbood, Mohammed and Hasan, Ali},
title = {Serum magnesium as a biochemical and pharmacological risk marker for arrhythmias in chronic cardiovascular disease},
journal = {Tropical Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {10},
pages = {1365--1371},
doi = {10.4314/tjpr.v25i10.4}
}
EUVIMED